Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Simon Fraser University

$25,000.00

Hyperspectral Scanning Laser Ophthalmoscope for Alzheimer's Disease

FY 2015-16

Summary
Alzheimer's Disease (AD) is commonly associated with neurodegeneration and an accumulation of senile plaques in the brain. Neurologists currently use radioactive labels to visualize the severity of the plaques in the brain, a process that is time consuming, costly, and exposes the patients to radiation. Recent research results suggest that the sample plaques are deposited in the neural tissues of the retina, located at the back of the eye. Dr. Sarunic and Canadian company Optina Diagnostics are each developing novel technology for visualization of the plaques in the retina minimally invasively in anticipation of lowering the costs of imaging and monitoring AD patients. The purpose of this research proposal is to investigate a novel optical imaging system using Optina's hyperspectral technology for detection of AD plaques in the eye. Dr. Sarunic's research group is experienced in the development of ophthalmic imaging systems, and interested in retinal diagnostics for AD. This Engage research project will facilitate a new collaboration, and the investigation of novel medical imaging instrumentation.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
490991-2015
Name nom
Sarunic, Marinko
Department département
Engineering Science, School of
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Hyperspectral Scanning Laser Ophthalmoscope for Alzheimer's Disease
Keyword
NSERC
Application summary
Alzheimer's Disease (AD) is commonly associated with neurodegeneration and an accumulation of senile plaques in the brain. Neurologists currently use radioactive labels to visualize the severity of the plaques in the brain, a process that is time consuming, costly, and exposes the patients to radiation. Recent research results suggest that the sample plaques are deposited in the neural tissues of the retina, located at the back of the eye. Dr. Sarunic and Canadian company Optina Diagnostics are each developing novel technology for visualization of the plaques in the retina minimally invasively in anticipation of lowering the costs of imaging and monitoring AD patients. The purpose of this research proposal is to investigate a novel optical imaging system using Optina's hyperspectral technology for detection of AD plaques in the eye. Dr. Sarunic's research group is experienced in the development of ophthalmic imaging systems, and interested in retinal diagnostics for AD. This Engage research project will facilitate a new collaboration, and the investigation of novel medical imaging instrumentation.